BCRX Earnings

BCRX reported its earnings on 2026-02-26, showcasing a revenue of against an estimate of 149.38M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.06 by 0%. The stock experienced a 4.64% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following BCRX's earnings announcement on 2026-02-26, the stock price moved by 4.64% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, BCRX's stock price tends to shift by an average of -5.41% in the 10 days leading up to earnings and -0.92% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate BCRX's annual revenue to reach 155.45M, while the EPS is projected at 0.07. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between BCRX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BCRX's stock price typically moves by -5.41% in the 10 days before its earnings and -0.92% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.07 and revenue of 155.45M.

The earnings call highlighted strong financial performance with record revenue growth and operating profit, coupled with strategic developments like the Astria acquisition and raised ORLADEYO guidance. The Q&A session revealed no major negative sentiments, though management was somewhat vague on certain timelines. The market's reaction is likely positive, driven by raised guidance, strong cash position, and strategic partnerships, despite some uncertainties. Given the company's small-cap status, the stock is expected to react positively, within the range of 2% to 8%.